One-Month Outcomes of Intravitreal Anti-VEGF vs. Dexamethasone Implant in the Treatment of Diabetic Macular Edema in Vitrectomized Eyes

One-Month Outcomes of Intravitreal Anti-VEGF vs. Dexamethasone Implant in the Treatment of Diabetic Macular Edema in Vitrectomized Eyes

ObjectivesTo compare short-term effect of intravitreal ranibizumab with dexamethasone implant for diabetic macular edema (DME) in vitrectomized eyes.MethodsSingle-center, prospective, randomized study of vitrectomized eyes with DME. Study eyes were divided into two groups, receiving ranibizumab (IVV...

Full description

Bibliographic Details
Main Authors: Youling Liang, Bin Yan, Manyun Xie, Zhishang Meng, Jiayue Ma, Bosheng Ma, Jing Luo
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Medicine
Subjects:
anti-vascular endothelial growth factor (VEGF)
anti-inflammation
diabetic macular edema
vitrectomized eyes
central retinal thickness (CRT)
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.895220/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.895220/full

Similar Items